Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Ltd. Common Shares (NY: BHVN )

35.33 -1.39 (-3.80%)
Streaming Delayed Price Updated: 11:37 AM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 375,721
Open 37.21
Bid (Size) 35.32 (1)
Ask (Size) 35.45 (3)
Prev. Close 36.72
Today's Range 34.20 - 37.21
52wk Range 26.80 - 62.21
Shares Outstanding 65,401,228
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
From Merus N.V.
Via GlobeNewswire
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up. 
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political

Performance

YTD
-5.24%
-5.24%
1 Month
-8.18%
-8.18%
3 Month
-33.06%
-33.06%
6 Month
-8.13%
-8.13%
1 Year
-20.80%
-20.80%

More News

Read More
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
Via Benzinga
BHVN Stock Earnings: Biohaven Misses EPS for Q2 2024
Via InvestorPlace
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Via Benzinga
Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study
Via Benzinga
Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Acuity Brands, Nike And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
Via MarketBeat
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Crude Oil Down Over 1%; US Manufacturing PMI Falls In September
Via Benzinga
Exposures Fossil Fuels
Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise
Via Benzinga
Exposures Product Safety
Biohaven, Tesla And Other Big Stocks Moving Higher On Monday
Via Benzinga
Biohaven Surges After Delaying Progression By Up To 70% In A Rare Disease
Via Investor's Business Daily
This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Biohaven Stock Earns Relative Strength Rating Upgrade
Via Investor's Business Daily
$1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
Via InvestorPlace
HP Posts Upbeat Earnings, Joins Foot Locker, American Superconductor, Red Robin Gourmet Burgers And Other Big Stocks Moving Higher On Thursday
Via Benzinga
After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
Via Investor's Business Daily
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.